Peptidase

Peptidases, also known as proteases or proteinases, are a diverse group of enzymes that catalyze the hydrolysis of peptide bonds within proteins and peptides (UniProt, 2023). They are classified into several catalytic types, including serine, cysteine, aspartic, and metallopeptidases, and are essential for a wide array of biological processes such as digestion, blood clotting, and the activation of zymogens (MEROPS Database, 2024). In a therapeutic context, peptidases are highly significant targets; for example, angiotensin-converting enzyme (ACE) inhibitors are used for hypertension, and dipeptidyl peptidase-4 (DPP-4) inhibitors are used for type 2 diabetes (PubMed, 2022). The designation "Peptidases not disclosed" is typically a placeholder used in clinical trial registries or patent filings when the specific enzyme target is withheld for proprietary reasons during early-stage drug development. Because the peptidase family is so vast and functionally diverse, the lack of a specific identity makes it impossible to definitively characterize the drug's precise mechanism or safety profile without further disclosure.

Other names

ProteaseProteinaseProteolytic enzymeExopeptidaseEndopeptidase

Inhibition of the catalytic activity of the enzyme to prevent the cleavage of specific peptide bonds in substrate proteins, thereby modulating physiological pathways or viral replication.